Intravascular Ultrasound Market Insights, Competitive Landscape, and Market Forecast - 2034

Intravascular Ultrasound Market Summary

• The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034, reflecting strong and sustained growth.
• The global intravascular ultrasound market is growing at a CAGR of 7.52% during the forecast period from 2026 to 2034.
• The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.
• The leading companies operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.
• North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.
• In the type segment of the intravascular ultrasound market, the IVUS catheters category is estimated to account for the largest market share in 2025.

Factors Contributing to the Growth of the Intravascular Ultrasound Market

• Rising prevalence of cardiovascular diseases and associated risk factors leading to a surge in intravascular ultrasound: The rising prevalence of cardiovascular diseases (CVDs) and associated risk factors such as hypertension, diabetes, obesity, and an aging population is significantly boosting the overall market for Intravascular Ultrasound (IVUS) systems.
• The expanding use of IVUS due to the surge in percutaneous coronary interventions (PCI) esclating the market of intravascular ultrasound: The expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI) is significantly driving the growth of the IVUS market. PCI procedures, such as angioplasty and stent placement, have become the preferred treatment option for coronary artery disease (CAD) due to their minimally invasive nature, reduced recovery time, and lower procedural risks compared to traditional coronary artery bypass grafting (CABG).
• Surging strategic activities such as acquisitions, partnerships, R&D, and others by key market players: The growing product development activities across the globe are a cornerstone of the booming intravascular ultrasound market. Advances in technology, expanding disease applications, approvals, and strategic collaborations are enabling the creation of innovative diagnostic solutions. With continued investment and innovation, intravascular ultrasound are set to transform healthcare by offering non-invasive, accurate, and personalized diagnostic tools for a wide range of diseases.

Intravascular Ultrasound Market Report Segmentation

This intravascular ultrasound market report offers a comprehensive overview of the global Intravascular Ultrasound market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing intravascular ultrasound market.

Intravascular ultrasound (IVUS), a catheter-based invasive imaging modality has applications in interventional cardiology for the characterization of lesion morphology, quantification of plaque burden, stent size guidance, assessment of stent expansion, and in identification of procedural complications.

The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

What are the latest intravascular ultrasound market dynamics and trends?

The global market for intravascular ultrasound has witnessed significant growth in recent years, largely driven by the rising prevalence of cardiovascular diseases (CVDs) and associated risk factors, the expanding use of Intravascular Ultrasound (IVUS) due to the surge in percutaneous coronary interventions (PCI), and increase in product development activities among the key market players.

According to the World Heart Federation (2024), approximately 60 million population was affected by atrial fibrillation which is one of the most common types of irregular heartbeat, or arrhythmia. It can increase the risk of blood clots, heart failure and stroke. Additionally, as per the same source people with atrial fibrillation were 5X times more likely to suffer a stroke.

Atrial fibrillation, the most common cardiac arrhythmia, is associated with a heightened risk of thromboembolic events, stroke, and structural heart complications. As AF management increasingly involves catheter-based interventions such as pulmonary vein isolation (PVI), left atrial appendage (LAA) closure, and atrial fibrillation ablation, IVUS plays a critical role in guiding these procedures by providing real-time, high-resolution imaging of vascular structures and thereby boosting the overall IUVS market.

According to a recent data provided by British Heart Foundation (2024), globally, around 56 million women and 45 million men were stroke survivors. It's estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed. Congenital heart disease patients who undergo surgical corrections often need long-term monitoring and intervention, where IVUS serves as a minimally invasive diagnostic tool to assess graft patency, evaluate vascular remodeling, and detect post-surgical complications.

Additionally, according to the data provided by the University of Michigan (2024), more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.

As PCI becomes the primary treatment for CAD, interventional cardiologists increasingly rely on IVUS for enhanced procedural outcomes. Unlike traditional angiography, IVUS provides real-time, high-resolution cross-sectional imaging, enabling precise vessel assessment, plaque analysis, and optimal stent placement. This has driven higher IVUS adoption, improving PCI success rates and reducing complications, thereby boosting its market demand.

Thus, the growth of IUVS is closely linked to the annual volume of PCI procedures and the increasing integration of IVUS in both pre-stenting and post-stenting applications. For example, Boston Scientific offers the OPTICROSS(TM) HD Coronary Imaging Catheters, which provide high-definition imaging to assist in accurate stent placement and assessment of procedural results. Additionally, their AVVIGO(TM)+ Multi-Modality Guidance System integrates IVUS and Fractional Flow Reserve (FFR) capabilities, enhancing vessel imaging and physiological assessments during PCI.

Furthermore, the increase in product development activites are further boosting the overall market of IVUS. For instance, in March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.

Thus, the factors mentioned above are expected to boost the overall market of intravascular ultrasound during the forecast period from 202 to 2034.

However, IVUS catheter can sometimes cause mechanical trauma to the arterial wall during insertion, manipulation, or withdrawal lading to vessel dissection and presence of alternatives such as optical coherence tomography (OCT) and advanced angiography may limit the future market of IVUS during the forecast period.

Intravascular Ultrasound Market Segment Analysis

Intravascular Ultrasound Market by Type (IVUS Catheters and IVUS Consoles), Application (Coronary Interventions and Peripheral Interventions), End-Users (Hospitals and Clinics, Diagnostic Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Intravascular Ultrasound Market Regional Analysis

North America Intravascular Ultrasound Market Trends

North America is expected to account for the highest proportion of 43.72% of the Intravascular Ultrasound market in 2025, out of all regions. This domination is due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

According to the recent data provided by Centre for Disease Control and Prevention (2024), in 2022, approximately 4.8% of adults have been diagnosed with coronary heart disease. Patients with CHD develop atherosclerosis, leading to restricted blood flow and a higher risk of heart attacks. As CHD cases rise, the demand for advanced imaging technologies like IVUS increases for diagnosis, thereby driving market growth.

Moreover, according to the data provided by the Centre for Disease Control and Prevention (2024), the prevalence of obesity among adults was 40.3% during 2021 to 2023. Excess weight leads to metabolic disorders, accelerating plaque buildup and increasing the need for PCI. Thus, IVUS plays a key role in guiding stent placement and optimizing treatment, thereby driving its market growth.

Additionally, according to the data provided by the University of Michigan (2025), angioplasty is done on more than a million people a year in the United States. During angioplasty, IVUS helps in accurate assess of plaque and lesion characteristics, guide stent placement and expansion as a result, IVUS adoption is expected to escalate in the region.

Thus, all the above-mentioned factors are anticipated to propel the market for intravascular ultrasound in the United States during the forecast period.

Europe Intravascular Ultrasound Market Trends

In Europe, the growth of the intravascular ultrasound market is being strongly driven by the rising prevalence of cardiovascular disorders, risk factors such as diabetes, obesity, and high blood pressure across the region thereby boosting the overall market of IVUS market.

According to the data provided by the British Heart Foundation (2024), 7.6 million people are living with heart and circulatory disease. The rising incidence of conditions like atherosclerosis, heart attacks, and strokes is driving the demand for advanced diagnostic tools such as intravascular ultrasound (IVUS), as it provides real-time imaging of coronary arteries and helps in the assessment of plaque buildup, vessel diameter, and stent placement.

Additionally, according to the data provided by the Diabetes UK Organization (2024), in 2023-2024, approximately 5.8 million people in the UK were living with diabetes.

Furthermore, according to the data provided by the Government of UK (2024), 63.8% of adults aged 18 and over were overweight or living with obesity in the United Kingdom.

Moreover, the stats provided by the British Heart Foundation (2025), five million adults in the UK had undiagnosed high blood pressure. Thus, the rising prevalence of risk factors such as diabetes, obesity, and hypertension increases the adoption rate of IVUS-guided interventions to improve procedural outcomes, reduce post-surgical complications, and enhance long-term patient survival rates.

Hence, all the factors mentioned above are expected to drive the market for intravascular ultrasound in the United Kingdom during the forecast period.

Asia-Pacific Intravascular Ultrasound Market Trends

The Asia Pacific region is projectd to grow at a healthy CAGR of 8.86% during the forecast period from 2026 to 2034 and is emerging as a significant growth driver for the intravascular ultrasound market, fueled by rising growing geriatric population and the increasing prevalence of cardiological disorders and associated risk factors.

As per the recent study published in the Journal of National Library of Medicine 2024, it was estimated that approximately 330 million individuals in China are affected by CVD on average.

Among them, there are 13 million cases of stroke, 11.4 million cases of coronary heart disease, 5 million cases of pulmonary heart disease, 8.9 million cases of heart failure, 4.9 million cases of atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of lower extremity artery disease, and 245 million cases of hypertension.

Additionally, according to the IDF Diabetes Atlas (2024), in 2045, the age-adjusted comparative prevalence of diabetes would increase to 12.6% in China.

As these conditions often involve complex arterial blockages and atherosclerosis, IVUS plays a crucial role in providing high-resolution, real-time imaging of blood vessels, allowing cardiologists to assess plaque burden, vessel size, and lesion characteristics with precision. This enhances the accuracy of percutaneous coronary interventions (PCI) by optimizing stent placement and reducing complications like restenosis and stent thrombosis and thereby boosting the overall market of IUVS.

Who are the major players in the intravascular ultrasound market?

The following are the leading companies in the intravascular ultrasound market. These companies collectively hold the largest market share and dictate industry trends.

• Koninklijke Philips N.V.
• Boston Scientific Corporation
• Terumo Corporation
• NIPRO
• CONAVI MEDICAL
• Bracco
• Intravascular Imaging Incorporated (i3)
• Insight Lifetech Co., Ltd.
• Shanghai Pulse Medical Technology Inc.
• MicroPort Scientific Corporation
• Provisio Medical, Inc.
• Others

How is the competitive landscape shaping the intravascular ultrasound market?

The intravascular ultrasound (IVUS) market is characterized by a moderately to highly concentrated competitive landscape, dominated by a small group of global medtech leaders most notably Boston Scientific, Philips Healthcare, Terumo, and Medtronic which together account for over half of the total market share, driven by their strong cath-lab presence, broad imaging portfolios, and long-standing clinician trust. These players shape competition through continuous product innovation, AI-enabled imaging enhancements, integration with interventional platforms, and strategic acquisitions, reinforcing high entry barriers for new entrants. At the same time, smaller and niche companies compete by focusing on differentiated catheter technologies, hybrid imaging, or cost-effective solutions tailored to specific regions, particularly in emerging markets. As a result, while large incumbents maintain pricing power and scale advantages, ongoing technological advancements and clinical demand for precision-guided interventions ensure the market remains competitive rather than fully consolidated.

Recent Developmental Activities in the Intravascular Ultrasound Market

• In March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System.
• In October 2024, MicroPort(R) MicroImaging, a subsidiary of MicroPort Scientific Corporation, obtained approval from the National Medical Products Administration (NMPA) for the marketing of its Decypher(TM) IVUS Diagnostic System and Outsight(R) Disposable IVUS Diagnostic Catheter.
• In May 2024, Provisio Medical, Inc., announced the completion of the first commercial clinical cases utilizing the Provisio(TM) SLT IVUS(TM) System.
• In April 2024, Provisio Medical's Provisio(TM) SLT IVUS(TM) System received FDA 510(k) clearance, introducing Sonic Lumen Tomography (SLT) technology for real-time, automatic blood vessel lumen measurement without complex image interpretation. It is the first integrated intravascular imaging and support crossing catheter, enabling simultaneous lumen measurement, visualization, guidewire support, and contrast agent delivery, enhancing vascular procedures.
• In October 2023, Evident Vascular exits stealth with US$35 million Series A funding to develop intravascular imaging platform.

Intravascular Ultrasound Market Segmentation

• Intravascular Ultrasound by Type Exposure
• IVUS Catheters
• IVUS Consoles
• Intravascular Ultrasound Application Exposure
• Coronary Interventions
• Peripheral Interventions
• Intravascular Ultrasound End-Users Exposure
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Others
• Intravascular Ultrasound Geography Exposure
• North America Intravascular Ultrasound Market
• United States Intravascular Ultrasound Market
• Canada Intravascular Ultrasound Market
• Mexico Intravascular Ultrasound Market
• Europe Intravascular Ultrasound Market
• United Kingdom Intravascular Ultrasound Market
• Germany Intravascular Ultrasound Market
• France Intravascular Ultrasound Market
• Italy Intravascular Ultrasound Market
• Spain Intravascular Ultrasound Market
• Rest of Europe Intravascular Ultrasound Market
• Asia-Pacific Intravascular Ultrasound Market
• China Intravascular Ultrasound Market
• Japan Intravascular Ultrasound Market
• India Intravascular Ultrasound Market
• Australia Intravascular Ultrasound Market
• South Korea Intravascular Ultrasound Market
• Rest of Asia-Pacific Intravascular Ultrasound Market
• Rest of the World Intravascular Ultrasound Market
• South America Intravascular Ultrasound Market
• Middle East Intravascular Ultrasound Market
• Africa Intravascular Ultrasound Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-Powered Innovations and Applications in IVUS are rapidly transforming how intravascular ultrasound is performed and interpreted, moving the technology beyond manual image review toward automated, data-driven clinical decision support. Modern AI algorithms especially deep learning models are being developed to automatically segment lumen, vessel walls, plaque, and stent structures with high accuracy, significantly reducing the need for manual annotation and inter-operator variability during IVUS interpretation. These models can classify vessel components (e.g., calcification or narrow lumina), quantify key anatomical metrics, and assist in lesion characterization, which can improve diagnostic consistency and support treatment planning. AI is also being used to predict procedural outcomes (such as regions affected by rotational atherectomy) and may be extended to broader risk prediction models for adverse cardiovascular events by integrating IVUS imaging with clinical and demographic data. Beyond direct clinical interpretation, AI is accelerating clinician training and proficiency-for example, adaptive educational platforms powered by AI provide personalized, case-based IVUS learning pathways that build pattern recognition and decision-making skills more efficiently. Together, these innovations aim to enhance workflow efficiency, standardize image analysis, and expand the utility and adoption of IVUS in cardiovascular interventions

U.S. Tariff Impact Analysis on Intravascular Ultrasound Market:

The U.S. tariff impact on the Intravascular Ultrasound (IVUS) market reflects broader strains on the U.S. medical device sector caused by recent tariff policies aimed at reshoring manufacturing and reducing dependence on foreign supply chains. Under new trade measures, tariffs of up to double-digit percentages on imported medical devices and components including diagnostic and imaging equipment have been implemented, significantly increasing manufacturing and procurement costs for devices or parts sourced from China, the EU, and other regions, which are crucial suppliers for advanced cardiovascular technologies like IVUS. These heightened duties place margin pressure on both U.S. and foreign IVUS manufacturers, who may face cost-pass-through to hospitals and healthcare providers or absorb higher input costs, potentially slowing adoption in cost-sensitive environments and delaying upgrades of imaging technologies. Supply chain disruptions caused by tariffs make long-established global production networks less efficient, spurring some firms to consider reshoring or diversifying supply bases, but such shifts are costly and time-intensive due to regulatory approvals and manufacturing retooling. Ultimately, tariff-driven cost increases and uncertainty could constrain growth in the U.S. IVUS market by elevating prices, creating procurement challenges for healthcare providers, and dampening demand for cutting-edge imaging modalities unless mitigated by policy adjustments or tariff exemptions for critical medical technologies.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the intravascular ultrasound market report study

• Market size analysis for the current intravascular ultrasound market size (2025), and market forecast for 8 years (2026 to 2034)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the intravascular ultrasound market.
• Various opportunities available for the other competitors in the intravascular ultrasound market space.
• What are the top-performing segments in 2025? How these segments will perform in 2034?
• Which are the top-performing regions and countries in the current intravascular ultrasound market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the intravascular ultrasound market growth in the future?

Frequently Asked Questions for the Intravascular Ultrasound Market

1. What is the growth rate of the intravascular ultrasound market?

• The intravascular ultrasound market is estimated to grow at a CAGR of 7.52% during the forecast period from 2026 to 2034.

2. What is the market for intravascular ultrasound?

• The global intravascular ultrasound market is expected to increase from USD 926.94 million in 2025 to USD 1,774.19 million by 2034.

3. Which region has the highest share in the intravascular ultrasound market?

• North America is expected to dominate the overall intravascular ultrasound market due to the rising cases of cardiovascular disorders and its risk factors. Additionally, the increasing number of angioplasty procedures across the region is further escalating the market of IVUS.

4. What are the drivers for the intravascular ultrasound market?

• The market of intravascular ultrasound is being primarily driven by the rising prevalence of cardiovascular diseases (CVDs), driven by risk factors such as aging populations, obesity, diabetes, and hypertension, is significantly boosting the demand for intravascular ultrasound (IVUS) as an essential diagnostic and interventional tool. With the increasing number of percutaneous coronary interventions (PCI) globally, IVUS is being widely adopted to enhance procedural precision, optimize stent deployment, and reduce complications such as restenosis. Additionally, key market players are accelerating growth through strategic acquisitions, partnerships, and R&D investments to develop advanced IVUS technologies, such as high-resolution imaging, 3D IVUS, and AI-driven analysis.

5. Who are the key players operating in the intravascular ultrasound market?

• Some of the key market players operating in the intravascular ultrasound market include Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, NIPRO, CONAVI MEDICAL, Bracco, Intravascular Imaging Incorporated (i3), Insight Lifetech Co., Ltd., Shanghai Pulse Medical Technology Inc., MicroPort Scientific Corporation, Provisio Medical, Inc., and others.